---
schema_version: "secwatch.filing_event.v1"
accession: "0000310764-22-000089"
form_type: "8-K"
ticker: "SYK"
cik: "0000310764"
company_name: "STRYKER CORP"
filed_at: "2022-07-26T23:59:59+00:00"
generated_at: "2026-06-24T08:53:54.013355+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Stryker Q2 organic sales +6.1% to $4.5B; lowers FY adjusted EPS guidance to $9.30-$9.50

## Summary
- Reported net sales of $4.5B (+4.6% YoY); organic net sales +6.1%.
- Reported EPS $1.72 (+11%); adjusted EPS of $2.25 flat YoY.
- MedSurg & Neurotechnology organic sales +7.9%; Orthopaedics & Spine organic +3.9%.
- Adjusted operating margin contracted 220 bps to 23.7%; FY22 organic sales guidance raised to 8-9%.

## SEC filing metadata
- accession: 0000310764-22-000089
- form_type: 8-K
- ticker: SYK
- cik: 0000310764
- company_name: STRYKER CORP
- filed_at: 2022-07-26T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/310764/000031076422000089/0000310764-22-000089-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/310764/000031076422000089/syk-20220726.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000310764-22-000089
- JSON: https://secwatch.observer/filing/0000310764-22-000089.json
- Plain text: https://secwatch.observer/filing/0000310764-22-000089.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.